Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Chengdu Origen Biotechnology Co., Ltd. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
age-related macular degeneration, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1033086
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.